Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page
Price
Target price
€4.01

€4.01

-3.020%
-0.045
-3.020%
€9.00

€9.00

 
Latest predictions
-
24.09.20
-
03.08.20
buy
€5.00
16.03.20
buy
-
11.01.20
buy
€12.00
20.09.19
buy
-
09.09.19
buy
Your prediction

Medigene AG Stock

Heavy losses for Medigene AG today as the stock fell by -€0.045 (-3.020%).
With 6 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of €9.00 there is potential for a 124.719% increase which would mean more than doubling the current price of €4.01 for Medigene AG.

Pros and Cons of Medigene AG in the next few years

Pros
1
Could be worthwhile Investment >10% per year
1
Innovative
Cons
1
Higher risks for its business
1
Dependend from some customers or products

Comments

Buy Medigene AG

Sell Medigene AG

Published 24.01.20
Prediction Buy
Perf. (%) 7.084%
Target price
Change

Buy beendet

Show more
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more

Other discussions about Medigene AG Stock

Trading Medigene AG

Trading Medigene AG

New thread Forum

News

Medigene AG: Strategic measures including restructuring with extension of cash runway and improved EBITDA

Business news for the stock market

Planegg/Martinsried (22.09.2020) - 22 September 2020. Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical stage immuno-oncology company focusing

Medigene provides Q2 update and 6M report 2020

Conference call on 7 August 2020 at 2pm CET (Frankfurt) / 8am EDT (New York)

 

Business news for the stock market

 

Martinsried/ Munich (07.08.2020) - Medigene AG (Medigene, FSE: MDG1, Prime